ENTITY

Tobira Therapeutics (TBRA US)

1
Analysis
Health CareUnited States
Tobira Therapeutics Inc operates as a biopharmaceutical company. The Company focuses on developing and commercializing innovative therapeutics to treat liver diseases, human immunodeficiency virus, and fibrosis and inflammation. Tobira Therapeutics conducts business in the United States.
more
Refresh
25 Nov 2016 12:32

Saroglitazar: Targeting Non-Alcoholic Steatohepatitis, a Potential US$35-40 Billion Market.

Nonalcoholic fatty liver disease (NAFLD), a disorder characterized by fatty changes (and fibrosis in later stages) is expected to affect about 20...

No more insights
x